In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the ...

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

Dr. Gay concluded his presentation discussing phase l results of a trial assessing radium-223, peposertib, and avelumab in advanced mCRPC with the following take home points: The combination of radium ...

The analysis by Ontada tracked testing rates within the US Oncology Network for PD-L1, FGFR2/3, and HER2 biomarkers over 10 ...

New research looks at how machine learning models could be used to predict immunotherapy treatment outcomes for liver cancer patients. Immunotherapies are a type of cancer treatment that activate the ...

First-line immunotherapy of microsatellite instability-high metastatic colorectal cancer improved survival compared with chemotherapy. Certain patients with microsatellite stable disease also ...

This targeted antibody-based strategy represents new hope for patients with aggressive, treatment-resistant cancers, including those who have previously exhausted standard immunotherapy options.

Get Instant Summarized Text (Gist) Analysis of single-cell RNA and TCR sequencing from cancer patients treated with immunotherapy identified a distinct genetic signature in T cell clones of responders ...

School of Materials Science and Engineering, Anhui University, Hefei 230601, P.R. China ...

Roche’s Matteo Tonietto offered data on the idea that the ventricular expansion seen on immunotherapy represents fluid shifts, not atrophy. Altogether, these talks reflected refinement in how to use ...

A new immunotherapy drug could help some cancer patients avoid surgery. According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were ...